10/29/2024
3:30 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13G/A | |
09/05/2024
3:30 PM | Milestone Pharmaceuticals (Issuer)
PAPA JOSEPH C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2024
3:31 PM | Milestone Pharmaceuticals (Issuer)
PAPA JOSEPH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:07 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:15 PM | Milestone Pharmaceuticals (Issuer)
Wills Robert James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:15 PM | Milestone Pharmaceuticals (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:15 PM | Fischer Seth H. Z. (Reporting)
Milestone Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/29/2024
3:15 PM | Giles Lisa M. (Reporting)
Milestone Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:15 PM | Duty Stuart (Reporting)
Milestone Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:15 PM | Milestone Pharmaceuticals (Issuer)
Saik Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:28 PM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
3:16 PM | Milestone Pharmaceuticals (Issuer)
Saik Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2024
3:17 PM | Milestone Pharmaceuticals (Issuer)
Saik Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
5:06 PM | Alta Fundamental Advisers LLC (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13D/A | |
07/15/2024
3:38 PM | Milestone Pharmaceuticals (Filer)
| Form DEFA14A | |
07/15/2024
3:41 PM | Milestone Pharmaceuticals (Filer)
| Form ARS | |
07/15/2024
3:34 PM | Milestone Pharmaceuticals (Filer)
| Form DEF 14A | |
07/15/2024
3:36 PM | Milestone Pharmaceuticals (Filer)
| Form DEFA14A | |
05/29/2024
6:09 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:34 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
5:59 AM | Milestone Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
4:06 PM | Milestone Pharmaceuticals (Filer)
| Form 10-K/A | |
04/08/2024
3:38 PM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:07 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:21 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:01 AM | Milestone Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
8:00 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:52 PM | Milestone Pharmaceuticals (Filer)
| Form 424B5 | |
02/26/2024
6:06 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:56 PM | Milestone Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
6:10 AM | Milestone Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
6:41 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/29/2024
3:42 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/26/2023
6:15 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:05 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
5:37 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
5:09 AM | Milestone Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
3:43 PM | Alta Fundamental Advisers LLC (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13D | |
11/07/2023
8:07 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy MIST with Qtrade Free MIST Stock Alerts